These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6420922)

  • 41. Haemostatic function in coronary artery disease (CAD).
    Gupta A; Sikka M; Madan N; Dwidedi S; Rusia U; Sharma S
    Indian J Pathol Microbiol; 1997 Apr; 40(2):133-7. PubMed ID: 9257498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
    Kelsey PR; Stevenson KJ; Poller L
    Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.
    Chantarangkul V; Clerici M; Bressi C; Giesen PL; Tripodi A
    Haematologica; 2003 May; 88(5):547-54. PubMed ID: 12745274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lupus anticoagulants in children.
    Singh AK; Rao KP; Kizer J; Lazarchick J
    Ann Clin Lab Sci; 1988; 18(5):384-7. PubMed ID: 3140708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lupus anticoagulants.
    Shapiro SS; Thiagarajan P
    Prog Hemost Thromb; 1982; 6():263-85. PubMed ID: 6820164
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs.
    Martini WZ; Dubick MA; Wade CE; Holcomb JB
    Crit Care Med; 2007 Jun; 35(6):1568-74. PubMed ID: 17452929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laboratory support in the diagnosis of coagulation disorders.
    Giddings JC; Peake IR
    Clin Haematol; 1985 Jun; 14(2):571-95. PubMed ID: 3899445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The lupus anticoagulant. High incidence of 'negative' mixing studies in a human immunodeficiency virus-positive population.
    Clyne LP; Yen Y; Kriz NS; Breitenstein MG
    Arch Pathol Lab Med; 1993 Jun; 117(6):595-601. PubMed ID: 8503730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemostatic defect due to acquired circulating inhibitors against lipid procoagulant and factor VIII.
    Pechet L; Snyder LM; Chesney C; Colman RW
    Thromb Diath Haemorrh; 1974 Sep; 32(1):90-104. PubMed ID: 4548947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet function, coagulation tests, and cardiopulmonary bypass: lack of correlation between pre-operative and intra-operative whole blood lumiaggregometry and peri-operative blood loss in patients receiving autologous platelet-rich plasma.
    Irani MS; Izzat NN; Jones JW
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):428-32. PubMed ID: 8589209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.
    Gastineau DA; Kazmier FJ; Nichols WL; Bowie EJ
    Am J Hematol; 1985 Jul; 19(3):265-75. PubMed ID: 3925759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clotting defect in SLE.
    Byron MA
    Clin Rheum Dis; 1982 Apr; 8(1):137-51. PubMed ID: 6811189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solvent extraction of test plasmas for improved recovery of lupus anticoagulant activity.
    Exner T; Papadopoulos G; Sahman N; Koutts J
    Thromb Haemost; 1990 Aug; 64(1):121-3. PubMed ID: 2125754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of platelet contractile force as a research and clinical measure of platelet function.
    Carr ME
    Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant.
    Firkin BG; Booth P; Hendrix L; Howard MA
    Am J Hematol; 1978; 5(2):81-92. PubMed ID: 736036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The lupus anticoagulant in 14 male patients.
    Waddell CC; Brown JA
    JAMA; 1982 Nov; 248(19):2493-5. PubMed ID: 6813513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Factor XIIa-inhibited diluted thromboplastin time can reflect coagulation process].
    He S; Xiong S; He R; He X; Liu F; Han J; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):118-21. PubMed ID: 11876967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transient appearance of the lupus anticoagulant in three family members sharing the A11B35DR4 haplotype.
    Bussel J; Miller S; Hilgartner M; O'Reilly R; Kempin S; Pollack M; Miller D
    Am J Pediatr Hematol Oncol; 1983; 5(3):275-8. PubMed ID: 6414325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.